NCT00802776

Brief Summary

Penetrating keratoplasty (PKP) is corneal transplantation performed by using round trephine blades to create matched circumferential incisions in both the diseased cornea and the donor cornea. The donor tissue graft is then secured in place with sutures which are usually removed postoperatively.The primary surgical goals are the preservation of a clear graft and improvement of vision. Surgical outcomes are limited by donor-recipient junction mismatch, astigmatism, rejection, infection and wound dehiscence. The femtosecond laser is a focusable, infrared laser capable of cutting tissue at various depths and in a range of patterns, and is currently being used to create corneal lamellar flaps in LASIK surgery. The laser parameters can be adjusted for submicron precision in cutting desired diameters, depths and shapes in the cornea, with minimal collateral injury. This technology is now capable of creating full-thickness corneal trephinations with customized locking edges at the graft-host junction between the donor and recipient corneas in Femtosecond Laser-Assisted Keratoplasty (FLAK). This approach may allow for better wound junction of the donor and recipient corneas, which in turn may also significantly reduce astigmatism, improve wound healing and visual recovery. This pilot study will help us determine optimal femtosecond laser spot size, separation, fluence, and energy which result in the best graft-host fit. The specific aim is to investigate postoperative physiology and biomechanics after FLAK in human eyes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

December 4, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 5, 2008

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
5.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

March 15, 2017

Status Verified

March 1, 2017

Enrollment Period

3.2 years

First QC Date

December 4, 2008

Last Update Submit

March 13, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Investigate postoperative physiology and biomechanics after Femtosecond Laser Assisted Keratoplasty in human eyes.

    Preoperatively and 1day, 1week and 1, 3, 6, 12, 18 and 24 months post operatively

Study Arms (2)

FLAK

ACTIVE COMPARATOR

Femtosecond laser assisted keratoplasty

Procedure: Femtosecond laser assisted keratoplasty

PKP

ACTIVE COMPARATOR

Penetrating Keratoplasty

Procedure: PKP

Interventions

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Corneal opacification.
  • Reduced ETDRS-measured, best corrected, distance visual acuity to 20/40 or worse.
  • Ability to participate in follow-up visits.
  • Signed, informed consent.

You may not qualify if:

  • Corneal opacification adequately dense to obscure visualization of iris.
  • ETDRS-measured, best-corrected, distance visual acuity of 20/30 or better.
  • Corneal thickness greater than 1200 µm at the 9 mm peripheral zone.
  • Severe corneal thinning including descemetocoele with impending corneal rupture.
  • Prior PKP or incisional surgery that may provide a potential space into which the gas produced by the procedure can escape.
  • Poor visual potential in the non-study eye (VA of 20/100 or less, without potential for improvement by the examining ophthalmologist's judgment).
  • History of glaucoma, including steroid response rise in intraocular pressure.
  • Active intraocular inflammation or infection.
  • Age 18 or younger.
  • Unable to return for scheduled follow-up examinations.
  • Other medical condition(s) that will likely prevent long term follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cornea Clinic, Kellogg Eye Center

Ann Arbor, Michigan, 48105, United States

Location

MeSH Terms

Conditions

Keratoconus

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Study Officials

  • Shahzad Mian, MD

    University of Michigan Kellogg Eye Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
erry J Bergstrom Collegiate Professor of Resident Education in Ophthalmology and Visual Sciences and Associate Professor of Oph, Ophthalmology & Visual Science

Study Record Dates

First Submitted

December 4, 2008

First Posted

December 5, 2008

Study Start

October 1, 2007

Primary Completion

December 1, 2010

Study Completion

January 1, 2016

Last Updated

March 15, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

Locations